Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Cream

Innovative Treatment Approach Offers New Hope For Eczema Sufferers With Moderate To Severe Disease
Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals. PROTOPIC ointment (tacrolimus monohydrate) is already licensed to treat moderate and severe eczema (atopic dermatitis), often involving the treatment of flares as and when they occur.* It is now also approved for twice-weekly application to previously affected skin to prevent these exacerbations and prolong flare-free periods in PROTOPIC-responsive patients.ò€  Clinical studies have shown that this new approach brings significant benefits with over 40% of patients with moderate to severe eczema remaining flare-free for at least a year.1 Flares are known to place an enormous burden on patients. The International Study of Life with Atopic Eczema (ISOLATE) found that about 55% of these patients worried about the onset of their next exacerbation and that they spent on average over a third of the year (136 days) with their eczema in flare.2
generic viagra online
Kenya Seeks Support From PEPFAR To Expand Blood Transfusion Centers
Kenya"s Medical Services Permanent Secretary James Ole Kiyiapi announced Thursday that the government is in negotiations with PEPFAR for support in building additional blood transfusion centers in the country, Capital News reports. In an opening address at the 5th International Africa Society for Blood Transfusion, Ole Kiyiapi said the government estimates it will cost about Sh230 million ($2.99 million) to build the new centers and train appropriate staff. Purchase zoloft to treat depression.
News of the day
San Francisco Chronicle Profiles U.S. Global AIDS Coordinator
"Dr. Eric Goosby wasted no time starting his new job as the U.S. global AIDS coordinator. He flew from the Bay Area to Geneva hours after his confirmation by the Senate and was sworn in when he landed ò€¦ The ambassador is approaching his post with the urgency of a clinician who has spent more than 25 years fighting the disease," the San Francisco Chronicle writes.
Endocrinology

Nepean Dyspepsia Index Applies To Functional Dyspepsia In China

FD, a common non-organic disease in the world, greatly affects a patient"s quality of life. However, treatment of FD is still controversial and no single therapy is uniformly effective, due, in part, to absence of a reliable evaluation instrument. The Nepean Dyspepsia Index (NDI), measuring both symptom scores and impairment of the dyspepsia-specific health-related quality of life in FD patients, has been designed to diagnose FD and has been translated into several languages. Moreover, its utility has been proved to be validated by researches in western countries. However, DI has not been translated and validated in China. A research article published in the World Journal of Gastroenterology addresses this problem. The research team led by Professor Liang from Chengdu University of Traditional Chinese Medicine translated NDI and assessed the reliability and validity of this translated version in Chinese patients. According to the WHO-QOL methodology of cross-culture adaptation for quality of life, the NDI was formally translated from the original version into Chinese, including forward translation, back translation, a pretest and cross-cultural adaptation. In addition, internal consistency analysis with Cronbath"s alpha was performed to test its reliability. Pearson Item-Dimension Correlation coefficient was employed to evaluate content validity. Factor analysis and structural equation models were used to assess construct validity. The study indicated that the Chinese version of the NDI is a reliable and valid scale for measuring health-related quality of life (H-QOL) and disease severity in Chinese patients with functional dyspepsia. It is recommended to be used in FD-related clinical research in China in the future. Reference: Tian XP, Li Y, Liang FR, Sun GJ, Yan J, Chang XR, Ma TT,Yu SY, Yang XG. Translation and validation of the Nepean Dyspepsia Index for functional dyspepsia in China. World J Gastroenterol 2009; 15(25): 3173-3177 http://www.wjgnet.com/1007-9327/15/3173.asp Correspondence to: Fan-Rong Liang, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, China. Lin Tian World Journal of Gastroenterology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009